Concepedia

Association of serum B cell activating factor from the tumour necrosis factor family (BAFF) and a proliferation-inducing ligand (APRIL) with central nervous system and renal disease in systemic lupus erythematosus

Melissa Northcott, Alberta Hoi, Fabienne Mackay

Lupus · 2013 · 86 citations · 36 references

DOI

Abstract

Although neither serum BAFF nor APRIL correlated with disease activity in the overall population, elevated serum BAFF and reduced APRIL may be markers of renal and CNS disease in SLE patients.

References

36

The 1982 revised criteria for the classification of systemic lupus erythematosus

Eng M. Tan, Alan S. Cohen, James F. Fries et al. · Arthritis & Rheumatism · 1982 · 14.6K citations

, , +19

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

Emily C. Baechler, Franak Batliwalla, George Karypis et al. · Proceedings of the National Academy of Sciences · 2003 · 2.2K citations · Full text

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Sandra Navarra, Renato Guzmán, A Gallacher et al. · The Lancet · 2011 · 2K citations

, , +6

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

Richard Furie, Michelle Petri, Omid Zamani et al. · Arthritis & Rheumatism · 2011 · 1.6K citations · Full text

Mice Transgenic for Baff Develop Lymphocytic Disorders along with Autoimmune Manifestations

Fabienne Mackay, Stephen A. Woodcock, Pornsri Lawton et al. · The Journal of Experimental Medicine · 1999 · 1.5K citations · Full text